Detection of mutations in homologous recombination repair (HRR) genes in tumour tissue (TT) and circulating tumour DNA (ctDNA) from patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) in the phase III PROpel trial

Armstrong A. J., Saad F., Thiery-Vuillemin A., Oya M., Shore N. D., Mehra N., ...More

Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 9 - 13 September 2022, vol.33 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 33
  • Istanbul University Affiliated: No